In the experimental and control groups, the mean ALT, HBV DNA, and HAI levels at baseline, 3 months, and 12 months of treatment are shown in table 3.The mean ALT, HBV DNA, and HAI levels at the beginning of treatment were not significantly different between the experimental and control groups (P>0.05). This evidence concerns the gene GPT and nosocomial infection.